ArticleFrontiers in pharmacology2026
Protective effects of cannabidiol against acute stress: behavioral responses and corticosterone concentrations in female Wistar rats.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cannabidiol (CBD) has been widely investigated for its potential anxiolytic and stress-modulating effects. This study evaluated whether CBD reduces the stress response induced by acute restraint stress in rats. Methods: Thirty-six female Wistar rats were randomly assigned to six groups. Four experimental groups received CBD at different doses (2, 10, 20, and 100 mg/kg), while two control groups received the placebo (CBD vehicle medium-chain triglycerides). Sixty minutes after administration, the animals treated with CBD and one placebo-treated group (stressed control group) were subjected to 60 min of restraint stress. The other placebo-treated group (nonstressed control group) was not subjected to restraint stress. Subsequently, all animals were tested in the open field (OF) for 30 min. Immediately after the OF test, blood samples were collected for corticosterone analysis. Plasma corticosterone concentrations were determined using a commercial ELISA kit. Results: In the OF, distance traveled differed significantly between groups, although no significant differences were observed among the different CBD doses. Compared with stressed control rats, CBD-treated rats spent more time in the center of the OF arena, suggesting reduced anxiety-like behavior. Plasma corticosterone concentrations did not differ significantly between groups. At 90 min after the onset of stress (30 min after the end of restraint stress), corticosterone concentrations did not differ between CBD-treated and untreated rats. Conclusion: CBD showed no effect on locomotor activity but increased center time, suggesting anxiolytic-like effects. Further studies are needed to clarify the underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.